新たに診断された成人固体腫瘍がん患者のための同日の多学科クリニック:体系的なレビュー
John F Deeken1, Wayne Pereanu1, Raymond C Wadlow1
1Inova Schar Cancer Institute, Fairfax, VA.
JCO oncology practice
|February 20, 2026
まとめ
同日の多学科クリニック (MDC) は,がん治療を早め,診断から治療までの時間を短縮し,ガイドラインの遵守を改善します. 証拠によると,MDCは生存率と患者の満足度を高めることも示唆されています.
科学分野:
- 腫瘍学 腫瘍学
- 医療サービス 研究 医療サービス
- 臨床試験のデザイン
背景:
- 多学科クリニック (MDC) は,複雑ながんケアを簡素化するように設計されています.
- MDCsの比較効果と連続推薦の比較効果は十分に確立されていません.
研究 の 目的:
- 同日,コロッケ化された多学科クリニック (MDCs) の比較研究を体系的にレビューする.
- 癌治療の決定,ケアスケジュール,ガイドラインの遵守,患者の生存に対するMDCの影響を評価する.
主な方法:
- MEDLINE,Embase,CENTRALのデータベースを体系的にレビューした.
- MDCとルーティンケアを比較した27の観察コホートが含まれました.
- バイアスのリスクはROBINS-Iツールを使用して評価されました.
主要な成果:
- MDCは,診断から治療までの間隔を大幅に短縮しました (9.5日早く).
- ガイドラインの遵守は,通常のケア (68%) と比較して,MDC (91%) で高かった.
- メタアナリシスは,MDCの全生存率 (HR,0.77) の改善と,高い患者満足度 (>90%) を示した.
結論:
- 観察データは,MDCががん治療を加速し,ガイドラインの遵守を改善し,潜在的に生存率を向上させることを示しています.
- 高い患者満足度と中立的な自費費用が観察されました.
- ランダム化または準実験的設計を用いたさらなる研究は,因果関係を確認するために推奨されます.
さらに関連する動画
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.2K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K
関連する概念動画
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
